SOPHiA GENETICS SA (SOPH)
NASDAQ: SOPH · Real-Time Price · USD
3.110
-0.030 (-0.96%)
At close: Aug 13, 2025, 4:00 PM
3.150
+0.040 (1.29%)
Pre-market: Aug 14, 2025, 4:11 AM EDT
SOPHiA GENETICS Market Cap
SOPHiA GENETICS has a market cap or net worth of $210.17 million as of August 14, 2025. Its market cap has decreased by -30.86% in one year.
Market Cap
210.17M
Enterprise Value
179.16M
1-Year Change
-30.86%
Ranking
Category
Stock Price
$3.11
Market Cap Chart
Since the IPO on July 23, 2021, SOPHiA GENETICS's market cap has decreased from $1.12B to $210.17M, a decrease of -81.24%. That is a compound annual growth rate of -33.80%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 12, 2025 | 212.20M | 4.04% |
| Dec 31, 2024 | 203.97M | -33.51% |
| Dec 29, 2023 | 306.77M | 131.92% |
| Dec 30, 2022 | 132.27M | -85.31% |
| Dec 31, 2021 | 900.39M | -19.63% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 592.95B |
| Johnson & Johnson | 420.06B |
| AbbVie | 355.91B |
| UnitedHealth Group | 246.17B |
| AstraZeneca | 240.81B |
| Novartis AG | 234.72B |
| Novo Nordisk | 227.37B |
| Abbott Laboratories | 225.22B |